Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Bain Capital Says Not Looking At Worldline - Bloomberg
-
European shares settle at one-month high; French politics in focus
-
Form D Bain Capital Beacon Hold
-
Wrightwell, Formerly Vantage, Secures New Financing Round and Partners with Bain Capital and Saluda Grade to Invest Up To $300M in U.S. Housing
-
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
-
Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
-
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
-
Bain-backed Kioxia sets price range for December IPO
-
Virgin Australia gets interim nod to start selling new Qatar routes
-
AM Best Assigns Credit Ratings to Fed Re Ltd.
-
Burlington Stores, Inc. Reports Third Quarter 2024 Earnings
-
Explainer-What's behind the private equity battle for Fuji Soft?
-
Halcyon Closes $100M Series C Funding Round at $1 Billion Valuation to Protect Society from Ransomware Disruption
-
BAIN CAPITAL COMPLETES ACQUISITION OF ENVESTNET
-
Seven & i founding family sounded out KKR, others about buyout, Nikkei says
-
Lattice Semiconductor (LSCC) Said To Consider Making Offer For Intel's Altera Unit - Bloomberg
-
Form 8-K Bain Capital Private For: Nov 22
-
Kioxia's market value set at $4.9 billion in IPO
-
Surf Internet Reaches Major Milestone of 50,000 Fiber-Optic Internet Subscribers
-
Cloud Security Leader Sysdig Appoints William Welch CEO to Accelerate Growth and Global Footprint
-
Zero Hash Ranked Number 4 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
-
VISO TRUST Secures $24M to Accelerate Innovation in AI-Powered Third-Party Risk Management
-
/C O R R E C T I O N -- VISO TRUST/
-
Almaviva and OverIT team up on Field Service digital transformation in the Infrastructure and Transportation sector
-
Exclusive-Kioxia market value set at $5 billion, Japan chipmaker to receive listing approval, sources say
-
StoryCatch Partners Acquires EmpiraMed
-
Flex (FLEX) to Join S&P MidCap 400; Azenta (AZTA) and Concentra Group Holdings (CON) to Join S&P SmallCap 600
-
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
-
Veza Recognized as a CRN® 2024 Stellar Startup!
-
Form 8-K Bain Capital Private For: Nov 13
-
Edward Woodford, Founder and CEO of Zero Hash recognized as 2025 Chicago Titan 100
-
Arc Launches First AI Platform For $2 Trillion Private Credit Industry
-
BW Fusion, Biodyne, and Agronomy 365 Join to Revolutionize Agriculture Industry, Supported by Bain Capital Double Impact
-
Gather AI Expands Inventory Intelligence Solution into Freezer & Cold Storage Warehouse Environments
-
Canapi Ventures Welcomes New Principals Kristie Han and Connie Qian
-
AVCJ announces Asian Private Equity & Venture Capital Awards 2024 winners
-
B Capital Appoints Timur Akazhanov as General Partner
-
Bain Capital Closes Global Special Situations Fund
-
Aggie Makes Social Media Not Suck
-
Alkeus Pharmaceuticals Receives FDA Rare Pediatric Disease and Fast Track Designations for Gildeuretinol as a Treatment for Stargardt Disease
-
Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form D/A Bain Capital Public Equi
-
KKR Receives Support and Recommendation from FUJI SOFT for Second Tender Offer and Expects to Launch Tender Offer Next Week
-
KKR raises tender offer price for Fuji Soft acquisition
-
Form SC 13G/A NaaS Technology Inc. Filed by: Bain Capital Rise Education IV Cayman Ltd
-
Form SC 13G/A Disc Medicine, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SC 13G/A BRP Inc. Filed by: Bain Capital Integral Investors II, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.

